SRF’s persistent pain point hampers investors’ confidence on earnings outlook

The management reiterated its 15-20% revenue growth guidance for the chemicals business and expects to deliver at the higher end of the range in FY27The management reiterated its 15-20% revenue growth guidance for the chemicals business and expects to deliver at the higher end of the range in FY27 

Related Articles

Latest Articles